Login to Your Account



Other News To Note


Friday, July 13, 2012

• AVI BioPharma Inc., of Bothell, Wash., said it changed its name to Sarepta Therapeutics Inc. and its stock ticker to "SRPT." The firm also effected a 1-for-6 reverse stock split. The firm is working on RNA-based therapeutics, including lead drug eteplirsen for Duchenne's muscular dystrophy.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription